RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Comparison of Eptifibatide and Abciximab as Adjunct to Primary PCI
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 7
SP 21
OP 21
DO 10.1177/155989770700700715
UL http://mdc.sagepub.com/content/7/7/21.1.abstract
AB The EVA-AMI trial compared two intravenous glycoprotein IIb/IIIa inhibitors (GPI), eptifibatide and abciximab, as adjuncts to primary percutaneous coronary intervention (PCI) with respect to several measures of myocardial perfusion. The study represents the first head-to-head comparison of two GPIs in primary PCI for ST-elevation myocardial infarction.